Comparing treatments for a failing surgical aortic valve
Part of Heart & circulation clinical trials.
This trial compares two ways to treat a failing aortic valve that was replaced with a tissue valve during surgery: another surgical replacement or a less invasive catheter-based valve-in-valve procedure. It is for people with low to intermediate surgical risk who are between 18 and 75 years old.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a surgically placed aortic valve that is now failing (narrowing or leaking).
- You are between 18 and 75 years old.
- Your risk of death from surgery is less than 8% (low to intermediate risk).
- Your heart team thinks both options (replacing the valve again or doing a valve-in-valve procedure) are reasonable for you.
- You do not have an active infection in your heart valve, and you do not need other heart valve surgery at the same time.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two types of replacement heart valves (balloon-expandable and self-expanding) for people whose prior surgical aortic valve is no longer working. It looks at which valve type offers better outcomes when placed through a catheter in the leg.
This trial compares two ways to fix a heart valve replacement that is no longer working well. One option is to remove the old valve and put in a new one, and the other is to place a new valve inside the old one.
This trial compares two different types of replacement heart valves for people whose previous surgical aortic valve has failed. Both valves are placed using a less invasive method (through a leg artery), and the study aims to see which option works better for this 'valve-in-valve' procedure.
This trial compares two newer types of replacement heart valves (SAPIEN 3 Ultra Resilia and Evolut FX) to see which one works better for people with severe aortic stenosis, a condition where the heart's main valve becomes narrow. If you join, you'll be randomly assigned to receive one of the two valves during your TAVI procedure.
This trial compares a less invasive valve replacement (TAVR) with traditional open-heart surgery for people with a specific type of severe aortic valve narrowing (bicuspid valve). It aims to see which approach works better for those at intermediate or low surgical risk.
This trial compares two ways to replace a narrowed heart valve in people with a bicuspid aortic valve. If you're 50 or older and need a new valve, this study can help figure out which approach works best.
Hear when a new Degenerative Aortic Valve Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.